Fig. 1
From: Acquired resistance to immunotherapy in MMR-D pancreatic cancer
Clinical Pattern of Acquired Resistance. Panel a shows CA 19–9 levels corresponding to the timeline showing therapy. Panel b shows axial CT images corresponding to the primary pancreatic mass before treatment with immunotherapy and during immunotherapy, and the ovarian mass that developed after 22 months of immunotherapy. Red circles indicate the pancreatic mass and the yellow circle indicates the ovarian mass. Panel b shows the pancreatic mass after chemotherapy and RT